Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts

Authors

Keywords

Journal

Volume 100, Issue 8, Pages 1267-1276

Publisher

Springer Nature

Online

2009-03-25

DOI

10.1038/sj.bjc.6604995

References

View 5 related references

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now